Meanwhile, the company's total income stood at Rs 1,547.68 crore in the quarter under review, down Rs 202 crore from Rs 1,750.15 crore in Q4 FY25. At the same time, the revenue jumped by Rs 68 crore ...

In a bid to empower women and improve their participation in the workforce, the Centre has launched a major infrastructure ...

Piramal Pharma Ltd. has reported a consolidated net loss of Rs 82 crore for the first quarter ended June 30, 2025. The Mumbai ...

Piramal Enterprises reports a 52% surge in Q1 profit to Rs 276 crore, driven by growth in net interest income and retail AUM. CFO Upma Goel resigns.

International Gemmological Institute India, Happiest Minds Technologies, GMR Airports and Blue Dart Express, among others, ...

But official figures tell a different story. The Ministry of Road Transport and Highways (MoRTH) reported only 42 collapses ...

Piramal Pharma reports a net loss of Rs 82 crore in Q1 FY2026, despite growth in CDMO and CHG businesses. Revenue dips slightly. Future aspirations include USD 2 billion revenue.

Piramal Pharma has reported a consolidated net loss of Rs 82 crore for the first quarter ended June 30, 2025.   The Mumbai-based drug firm had reported a loss of Rs 89 crore in the April-June quarter ...

Limited (HCAR) announced its financial results for 1QMY26 today, posting a profit after tax (PAT) of Rs. 828 million ...

Shares of Lodha Developers experienced a significant decline in yesterday's trade, dropping 5.96% to Rs 1,203.20. The stock was identified as one of the top losers on the Nifty Next 50 index on Monday ...